Is serum placental growth factor a prognostic marker for stage III colorectal cancer patients?

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Hepato-Gastroenterology

• Publication date

  2011-12-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.5754/hge11393PMID 22155858
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lymph Node Ratio as a Quality and Prognostic Indicator in Stage III Colon Cancer

  2011cited by this paper
• Preoperative Serum Placenta Growth Factor Level Is a Prognostic Biomarker in Colorectal Cancer

  2009cited by this paper
• Preoperative Serum Carcinoembryonic Antigen Level as a Predictive Factor of Recurrence After Curative Resection of Colorectal Cancer

  2008cited by this paper
• Role of placenta growth factor in malignancy and evidence that an antagonistic PlGF/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts

  2007cited by this paper
• VEGF/PLGF induces leukemia cell migration via P38/ERK1/2 kinase pathway, resulting in Rho GTPases activation and caveolae formation

  2007cited by this paper
• Prognostic Significance of Metastatic Lymph Node Ratio in Node-Positive Colon Carcinoma

  2007cited by this paper
• Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair.

  2006cited by this paper
• Estimates of the cancer incidence and mortality in Europe in 2006.

  2006cited by this paper
• Systemic therapy for colorectal cancer.

  2005cited by this paper
• Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes.

  2005cited by this paper
• Placenta growth factor is over-expressed and has prognostic value in human breast cancer.

  2005cited by this paper
• The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer.

  2004cited by this paper
• Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study.

  2003cited by this paper
• Prognostic significance of plasma placental growth factor levels in renal cell cancer: an association with clinical characteristics and vascular endothelial growth factor levels.

  2003cited by this paper
• Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions

  2001cited by this paper

• Serum PlGF and EGF are independent prognostic markers in non-metastatic colorectal cancer

  2019cites this paper
• Placental growth factor in cancer

  2014cites this paper